| 2918.16.10 | 00 | Gluconic acid | kg | 6% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 25% |
| 2918.19.12 | 00 | Mandelic acid | kg | Free | | 15.4￠/kg + 67.5% |
| 2918.19.60 | 00 | Malic acid | kg | 4% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2918.22.50 | 00 | Salts and esters of O-acetylsalicylic acid | kg | 6.5% | Free (A*,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 47.5% |
| 2918.29.04 | 00 | 2,3-Cresotic acid; 2-Hydroxybenzoic acid, calcium salt; 1-Hydroxy-2-naphthoic acid; 2-Hydroxy-1-naphthoic acid; 1-Hydroxy-2-naphthoic acid, phenyl ester; α-Resorcylic acid; γ-Resorcylic acid; and 5-Sulfosalicylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4￠/kg + 40% |
| 2918.29.08 | 00 | m-Hydroxybenzoic acid | kg | Free | | 15.4￠/kg + 40% |
| 2918.29.22 | 00 | p-Hydroxybenzoic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 48.5% |
| 2918.29.25 | 00 | 3-Hydroxy-2-naphthoic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 57% |
| 2918.29.30 | 00 | Gallic acid | kg | 1% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 2% |
| 2918.29.39 | 00 | 4,4-Bis(4-hydroxyphenyl)pentanoic acid; and 3,5,6-Trichlorosalicylic acid | kg | Free | | 15.4￠/kg + 57% |
| 2918.99.05 | 00 | p-Anisic acid; Clofibrate; 1,6-Hexanediol bis(3,5-dibutyl-4-hydroxy- phenyl)propionate; and 3-Phenoxybenzoic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 40% |
| 2918.99.06 | 00 | 1-Hydroxy-6-octadecyloxy-2-naphthalene- carboxylic acid; and 1-Hydroxy-6-docosyloxy-2-naphthalene- carboxylic acid | kg | Free | | 15.4￠/kg + 57% |
| 2918.99.18 | 00 | 4-(4-Chloro-2-methylphenoxy)butyric acid; p-Chlorophenoxyacetic acid; and 2-(2,4-Dichlorophenoxy)propionic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2918.99.20 | 15 | 2-Methyl-4-chlorophenoxyacetic acid | kg | | | |
| 2921.22.10 | 00 | Derived in whole or in part from adipic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 3.4% (SG) | 15.4￠/kg + 66.5% |
| 2921.42.21 | 00 | Metanilic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, L,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.42.22 | 00 | Sulfanilic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.1￠/kg + 3.3% (SG) | 15.4￠/kg + 60% |
| 2921.59.20 | 00 | 4,4'-Diamino-2,2'-stilbenedisulfonic acid | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 80% |
| 2922.19.20 | 00 | 4,4'-Bis(dimethylamino)benzhydrol (Michler's hydrol); 5'-[3'-(Dimethylamino)propyl]-10',11'- dihydro-5H'-dibenzo[a,b]cyclohept- en-5'-ol (Dibenzcarbinol); and 1-(p-Nitrophenyl)-2-amino-1,3- propanediol | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39% |
| 2922.49.40 | 15 | l-Aspartic acid | kg | | | |
| 2922.49.60 | 00 | 3-Aminocrotonic acid, methyl ester; and ￠/- α-Amino-1,4-cyclohexadiene-1- acetic acid | kg | Free | | 25% |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 34% |
| 2924.29.62 | 10 | Acetaminophen | kg | | | |
